Natera Announces Completion of Signatera™ Analysis from the CALGB (Alliance)/SWOG 80702 Randomized, Phase III Clinical Trial in Colorectal Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to Natera Announces Completion of Signatera™ Analysis from the CALGB (Alliance)/SWOG 80702 Randomized, Phase III Clinical Trial in Colorectal Cancer
(NASDAQ: NTRA) Delayed: 228.80 -2.61 (1.13%)
Previous Close $231.41    52 Week High $13.80 
Open $231.52    52 Week Low $6.52 
Day High $234.14    P/E N/A 
Day Low $219.50    EPS $0.00 
Volume 1,577,771